Sandra Calvin

Companies

• Travere Therapeutics, Inc.VP, Corp Controller and CAO Sep 23, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTravere Therapeutics, Inc. TVTX42,353 shares²$2.3M at $53.15Sep 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 15, 2026Sold 300 shares at $63.66 of Travere Therapeutics, Inc.²
• Sep 15, 2026Sold 800 shares at $62.85 of Travere Therapeutics, Inc.²
• Sep 15, 2026Sold 4,275 shares at $62.14 of Travere Therapeutics, Inc.²
• Sep 15, 2026Exercised options 1,625 shares at $20.46 of Travere Therapeutics, Inc.²
• Sep 15, 2026Exercised options 1,250 shares at $22.40 of Travere Therapeutics, Inc.²
• Sep 15, 2026Exercised options 2,500 shares at $27.50 of Travere Therapeutics, Inc.²
• Apr 14, 2026Sold 21,977 shares at $41.07 of Travere Therapeutics, Inc.³
• Apr 14, 2026Exercised options 6,500 shares at $20.46 of Travere Therapeutics, Inc.³
• Apr 14, 2026Exercised options 6,250 shares at $8.93 of Travere Therapeutics, Inc.³
• Apr 14, 2026Exercised options 2,500 shares at $22.40 of Travere Therapeutics, Inc.³
• Feb 3, 2026Sold 4,333 shares at $32.12 of Travere Therapeutics, Inc.⁴
• Jan 31, 2026Granted 15,180 shares of Travere Therapeutics, Inc.⁴
• Dec 24, 2025Sold 7,402 shares at $40.00 of Travere Therapeutics, Inc.⁵
• Dec 15, 2025Sold 2,910 shares at $36.00 of Travere Therapeutics, Inc.⁶
• Nov 4, 2025Sold 67,115 shares at $36.00 of Travere Therapeutics, Inc.⁷
• Nov 4, 2025Exercised options 6,250 shares at $8.93 of Travere Therapeutics, Inc.⁷
• Nov 4, 2025Exercised options 12,500 shares at $22.40 of Travere Therapeutics, Inc.⁷
• Nov 4, 2025Exercised options 15,000 shares at $27.50 of Travere Therapeutics, Inc.⁷
• Nov 4, 2025Exercised options 17,500 shares at $26.88 of Travere Therapeutics, Inc.⁷
• Nov 4, 2025Exercised options 10,000 shares at $25.25 of Travere Therapeutics, Inc.⁷
• Feb 11, 2025Sold 9,244 shares at $25.00 of Travere Therapeutics, Inc.⁸
• Feb 11, 2025Sold 15,000 shares at $25.00 of Travere Therapeutics, Inc.⁸
• Feb 11, 2025Exercised options 15,000 shares at $15.46 of Travere Therapeutics, Inc.⁸
• Feb 11, 2025Sold 10,000 shares at $25.00 of Travere Therapeutics, Inc.⁸
• Feb 11, 2025Exercised options 10,000 shares at $17.96 of Travere Therapeutics, Inc.⁸